Reproductive Endocrinology Luteal Phase

Effect of progesterone and 17-hydroxyprogesterone caproate on normal corpus luteum function

Aksel S, Jones GS

Published February 15, 1974 American Journal of Obstetrics and Gynecology, 118(4), 466-472
DOI 10.1016/s0002-9378(16)33685-7 PMID 4812567

RRM Academy Synopsis

Progesterone did not appear to lower the body's own progesterone

In 1974, eight women with infertility and normal corpus luteum function took part in a study. Progesterone given after ovulation did not lower their own progesterone. Blood progesterone rose in treated cycles. The uterine lining matched the expected day of the cycle.

Key Findings

  • Eight volunteers aged 26 to 35 had regular cycles and no cause found for their infertility. Each was studied in a control cycle and a treatment cycle.
  • Endometrial biopsies were in phase in all 8 women, in both the control and treatment cycles, dated from the estimated day of ovulation.
  • Progesterone treatment raised blood progesterone in treated cycles. Mean values in 6 treated cycles exceeded those in 28 normal cycles (P = 0.001).
  • The luteal span was prolonged an average of only 1 day, a change that was not significant (P > 0.05).
  • In the woman whose curves were compared, 17-hydroxyprogesterone caproate produced no significant change in blood progesterone.

Interpretation

This study followed eight women with infertility and normal corpus luteum function. Each woman's treatment cycle was compared with her own control cycle. The authors found that progesterone did not shut down the corpus luteum at the doses used. Progesterone did not lower the body's own progesterone or shorten the luteal phase. One woman given a higher dose had a longer luteal phase, by 5 days, with bleeding 36 hours after treatment stopped. The findings support larger studies of progesterone's effect on the corpus luteum.

RRM Context

Other drugs can lower blood progesterone and shorten the luteal phase when given after ovulation. These include several progestins and stilbestrol. Neither compound studied here did that. Progesterone and synthetic progestins are different compounds. RRM keeps the two words apart.

Abstract

A group of infertility patients were evaluated by an endometrial biopsy, timed with a basal body temperature chart, serum luteinizing hormone radioimmunassay to pinpoint ovulation, and daily serum progesterone values during a control and a treatment cycle. Progesterone in the suppository or intramuscular form and 17-hydroxyprogesterone caproate* were administered during the luteal phase to a group of volunteer patients with normal corpus luteum function to determine if these compounds would depress serum progesterone levels as do certain progestational agents. There was no apparent inhibition of corpus luteum function as no decrease in progesterone production occurred. Despite the additive effect of progesterone administration demonstrated by elevated serum levels, endometrial biopsies remained in phase when dated from the estimated day of ovulation.

Topics

By this author

Related research

Reproductive Endocrinology › Luteal Phase › Corpus Luteum Function · Menstrual Cycle › Cycle Physiology › Luteal Phase · Therapeutics › Hormonal Agents › Progesterone and Progestins
Sezer Aksel, Georgeanna S. Jones
S Aksel, G Jones
PMID 4812567 4812567 DOI 10.1016/s0002-9378(16)33685-7 10.1016/s0002-9378(16)33685-7 Aksel et al. 1974, Aksel 1974